BlackRock’s PAVmed PAVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $102K | Buy |
17,092
+14,676
| +607% | +$104K | ﹤0.01% | 4998 |
|
|
2026
Q1 | $24.5K | Buy |
2,416
+2
| +0.1% | +$19 | ﹤0.01% | 5270 |
|
|
2025
Q4 | $16K | Sell |
2,414
-8
| -0.3% | -$91 | ﹤0.01% | 5249 |
|
|
2025
Q3 | $31.3K | Hold |
2,422
| – | – | ﹤0.01% | 5066 |
|
|
2025
Q2 | $43.6K | Hold |
2,422
| – | – | ﹤0.01% | 5015 |
|
|
2025
Q1 | $52.4K | Hold |
2,422
| – | – | ﹤0.01% | 4918 |
|
|
2024
Q4 | $45.6K | Sell |
2,422
-75
| -3% | -$2.22K | ﹤0.01% | 4969 |
|
|
2024
Q3 | $92.1K | Hold |
2,497
| – | – | ﹤0.01% | 4683 |
|
|
2024
Q2 | $61.1K | Hold |
2,497
| – | – | ﹤0.01% | 4816 |
|
|
2024
Q1 | $160K | Hold |
2,497
| – | – | ﹤0.01% | 4639 |
|
|
2023
Q4 | $309K | Hold |
2,497
| – | – | ﹤0.01% | 4536 |
|
|
2023
Q3 | $331K | Sell |
2,497
-3
| -0.1% | -$465 | ﹤0.01% | 4536 |
|
|
2023
Q2 | $459K | Sell |
2,500
-410
| -14% | -$82K | ﹤0.01% | 4505 |
|
|
2023
Q1 | $489K | Sell |
2,910
-271
| -9% | -$57K | ﹤0.01% | 4535 |
|
|
2022
Q4 | $687K | Buy |
3,181
+20
| +0.6% | +$7.55K | ﹤0.01% | 4521 |
|
|
2022
Q3 | $1.22M | Sell |
3,161
-39
| -1% | -$22.1K | ﹤0.01% | 4406 |
|
|
2022
Q2 | $1.34M | Sell |
3,200
-7,287
| -69% | -$3.52M | ﹤0.01% | 4411 |
|
|
2022
Q1 | $6.23M | Sell |
10,487
-149
| -1% | -$111K | ﹤0.01% | 3836 |
|
|
2021
Q4 | $11.8M | Buy |
10,636
+184
| +2% | +$400K | ﹤0.01% | 3578 |
|
|
2021
Q3 | $40.2M | Buy |
10,452
+128
| +1% | +$404K | ﹤0.01% | 2806 |
|
|
2021
Q2 | $29.7M | Buy |
10,324
+648
| +7% | +$1.53M | ﹤0.01% | 3059 |
|
|
2021
Q1 | $19.3M | Buy |
9,676
+5,569
| +136% | +$8.37M | ﹤0.01% | 3204 |
|
|
2020
Q4 | $3.92M | Buy |
4,107
+177
| +5% | +$151K | ﹤0.01% | 3801 |
|
|
2020
Q3 | $3.15M | Buy |
3,930
+82
| +2% | +$73K | ﹤0.01% | 3762 |
|
|
2020
Q2 | $3.65M | Buy |
3,848
+3,700
| +2,500% | +$3.7M | ﹤0.01% | 3641 |
|
|
2020
Q1 | $131K | Buy |
148
+6
| +4% | +$4.91K | ﹤0.01% | 4307 |
|
|
2019
Q4 | $76K | Buy |
142
+32
| +29% | +$13.3K | ﹤0.01% | 4482 |
|
|
2019
Q3 | $48K | Sell |
110
-6
| -5% | -$2.74K | ﹤0.01% | 4543 |
|
|
2019
Q2 | $59K | Buy |
+116
| New | +$61.3K | ﹤0.01% | 4562 |
|
|
2018
Q2 | – | Sell |
-2
| Closed | -$1K | – | 5060 |
|
|
2018
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 4868 |
|
|
2017
Q4 | $2K | Hold |
2
| – | – | ﹤0.01% | 4815 |
|
|
2017
Q3 | $4K | Buy |
+2
| New | +$4.14K | ﹤0.01% | 4766 |
|
Other funds holding PAVM
BlackRock's PAVM Position: Q2 2026 in Review
BlackRock increased its PAVmed (PAVM) stake by 607% in Q2 2026, buying an estimated $104K and bringing the position to 17,092 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #4998.
BlackRock first reported a position in PAVM in Q3 2017 and has held it in 32 quarters since. The position peaked at $40.2M in Q3 2021. 3 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.
- BlackRock held 17,092 shares of PAVmed worth $102K as of Q2 2026.
- BlackRock bought 14,676 PAVmed shares in Q2 2026, an estimated $104K.
- PAVmed made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4998 holding.
- BlackRock first reported a position in PAVmed in Q3 2017 and has held it in 32 quarters since.
- BlackRock's PAVmed position peaked at $40.2M in Q3 2021.
- 3 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.